Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 142.99m |
Free float | 132.88m |
P/E (TTM) | -- |
Market cap | 1.03bn USD |
EPS (TTM) | -0.3508 USD |
Data delayed at least 15 minutes, as of Nov 09 2021.
More ▼
Press releases
- Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference
- Aurinia Announces Board Restructuring
- Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial
- Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Aurinia Pharmaceuticals Shareholder Calls for CEO Peter Greenleaf, Dr. Brinda Balakrishnan, and Dr. Robert Foster to Resign from the Board
- venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies
- Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results
- Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024
- ILJIN SNT Co., Ltd. Calls on Board of Aurinia Pharmaceuticals to Honor Shareholders’ Voices Expressed at the AGM
- Aurinia to Participate in Upcoming Investor Healthcare Conferences
More ▼